Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: MURTY PHARMACEUTICALS, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-13 to 2024-09-12
Current total value of award: $90784
Description: FY23. DRUG PRODUCT STABILITY STUDIES. PERIOD OF PERFORMANCE: SEPTEMBER 13, 2023 - SEPTEMBER 12, 2024